RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|8|976-986

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.8, 2011-10, pp. : 976-986

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 Associated Topoisomerase II&bgr; Kinase: A Potential Pharmacological Target for Viral Replication

By  

Current Pharmaceutical Design, Vol. 19, Iss. 26, 2013-08 ,pp. : 4776-4786

Bentham Science Publishers

Access to resources Recommend Favorite

Topoisomerase 1B as a Target Against Leishmaniasis

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 3, 2015-03 ,pp. : 203-210

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of target of rapamycin inhibitors

By Easton John B   Houghton Peter J  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. : 551-564

Informa Healthcare

Access to resources Recommend Favorite

High-throughput Screening Identifies Small Molecule Inhibitors of Molecular Chaperones

By  

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 473-492

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Topoisomerase I from Mycobacteria - A Potential Drug Target

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1995-2007

Bentham Science Publishers

Access to resources Recommend Favorite